Incannex Healthcare (IXHL) Construction in Progress (2023 - 2024)

Incannex Healthcare's (IXHL) quarterly Construction in Progress came in at $393000.0 in Q1 2024, down 4.61% quarter-over-quarter from $412000.0 in Q4 2023.

Incannex Healthcare (IXHL) Construction in Progress (2023 - 2024) Analysis & Trends

Incannex Healthcare has disclosed Construction in Progress across 2 years of filings, most recently posting $393000.0 for Q1 2024.

  • Construction in Progress for Q1 2024 came in at $393000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2024 was $393000.0 (changed N/A YoY), and the FY2023 annual result was $160000.0, changed N/A from the prior year.
  • Construction in Progress came in at $393000.0 for Q1 2024 at Incannex Healthcare, down from $412000.0 in the prior quarter.
  • In the past five years, Construction in Progress ranged from a high of $412000.0 in Q4 2023 to a low of $160000.0 in Q2 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Construction in Progress (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn -
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn -
10 Incannex Healthcare 45.81 Mn 45.81 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2024 393,000.00
Dec 31, 2023 412,000.00
Jun 30, 2023 160,000.00